Showing results (121-130 of 181) with videos related to
Sort By:
Pageof 19
NPJ Vaccines|March 24, 2022
Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropismEmily H Davis, Binbin Wang, Mellodee White, et al.NPJ Vaccines|March 18, 2022
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and developmentMegan A Files, Clairissa A Hansen, Vanessa C Herrera, et al.Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|November 14, 2015
Susceptibility of a North American Culex quinquefasciatus to Japanese Encephalitis VirusYan-Jang S Huang, Julie N Harbin, Susan M Hettenbach, et al.Viruses|February 28, 2023
Differences in Genetic Diversity of Mammalian Tick-Borne FlavivirusesKassandra L Carpio, Jill K Thompson, Steven G Widen, et al.Journal of Virology|November 14, 2014
A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic diseaseVanessa V Sarathy, Mellodee White, Li Li, et al.The Journal of General Virology|September 9, 2011
Flavivirus-induced antibody cross-reactivityKaren L Mansfield, Daniel L Horton, Nicholas Johnson, et al.Vaccine|March 30, 2010
Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activityThomas P Monath, Cynthia K Lee, Justin G Julander, et al.Clinical and Vaccine Immunology : CVI|July 20, 2007
Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responsesJennifer Schepp-Berglind, Min Luo, Danher Wang, et al.Emerging Infectious Diseases|January 14, 2004
Genetic variation among temporally and geographically distinct West Nile virus isolates, United States, 2001, 2002C Todd Davis, David W C Beasley, Hilda Guzman, et al.The Journal of Infectious Diseases|October 18, 2023
A Prototype-Pathogen Approach for the Development of Flavivirus CountermeasuresRichard J Kuhn, Alan D T Barrett, Aravinda M Desilva, et al.Pageof 19